Skip to main content

Table 4 Outcome characteristics of patients with isolated pulmonary Candida spp. colonization without pre-existing pneumonia (cohort 2)

From: Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects

 

Antifungal therapy (n = 44)

No antifungal therapy (n = 131)

p value

SOFA score (day 7)

7 (4; 10)

3 (1; 6)

0.003

Newly acquired pneumonia, n (%)

21 (47.7)

22 (16.8)

<0.001

Sepsis/severe sepsis, n (%)

18 (40.9)

27 (20.6)

0.01

Mechanical ventilation (h)

162 (140; 547)

152 (59; 242)

<0.001

Hospital stay (days)

31 (15; 53)

20 (10; 34)

0.004

ICU stay (days)

17 (10; 29)

7 (4; 12)

<0.001

In-hospital mortality, n (%)

22 (50)

39 (29.8)

0.02

  1. Data are presented as median (25 %; 75 %) quartile
  2. SOFA Sequential Organ Failure Assessment